Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

Identification and Analysis of In Vivo VEGF Downstream Markers Link VEGF Pathway Activity with Efficacy of Anti-VEGF Therapies

Zhuang, G and Schmidt, M and Yao, J and Wu, X and Kaminker, JS and Jurinka, SS and Kolumam, G and Chung, AS and Jubb, A and Modrusan, Z and Ozawa, T and James, CD and Phillips, H and Haley, B and Tam, RNW and Clermont, AC and Cheng, JH and Yang, SX and Swain, SM and Chen, D and Scherer, SJ and Koeppen, H and Yeh, RF and Yue, P and Stephan, JP and Hegde, P and Ferrara, N and Singh, M and Bais, C (2013) Identification and Analysis of In Vivo VEGF Downstream Markers Link VEGF Pathway Activity with Efficacy of Anti-VEGF Therapies. CLINICAL CANCER RESEARCH. pp. 3681-3692.

Item Type: Article
Additional Information: pubid: 115 nvp_institute: NIBR contributor_address: Genentech Inc, San Francisco, CA 94131 USA mallika.singh@novartis.com; Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA, Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA USA ; NCI, NIH, Div Canc Treatment & Diag, Nat Clin Target Validat Lab, Bethesda, MD USA ; Medstar Washington Hosp, Washington Canc Inst, Washington, DC USA ; Novartis Inst Biomed Res, Emeryville, CA USA ; Genentech Inc, San Francisco, CA 94131 USA; Bais, C; Genentech Inc, 1 DNA Way, San Francisco, CA 94131 USA
Date Deposited: 13 Oct 2015 13:13
Last Modified: 13 Oct 2015 13:13
URI: https://oak.novartis.com/id/eprint/21953

Search

Email Alerts

Register with OAK to receive email alerts for saved searches.